Severe respiratory failure in COVID-19: clinical, biological and imaging risk factors

Foto: Rawpixels
01/03/2020 - 01/02/2021
Judith Garcia Aymerich
Barcelona Respiratory Network Foundation, ISGlobal and participating hospitals, and AstraZeneca

Although the majority (80%) of those infected with SARS-CoV-2 present mild coronavirus disease 2019 (COVID-19) characterized by unspecific symptoms, around 15% develop severe pneumonia requiring hospitalization, and approximately 5% (critical COVID-19) of all the infected develop severe acute respiratory failure (with or without acute respiratory distress), septic shock, and / or multiorgan failure requiring care in an intensive care unit (UCI). The evolution of the patient from a serious condition to a critical stage often occurs quickly and insidiously, so the clinicians have little time to react.

To date, it is unknown which factors, apart from aging and the presence of chronic diseases, can predict the evolution of COVID-19 from severe to critical disease. The objectives of the CORSAIR study are:

  • To estimate the association between risk factors (clinical, biological and imaging) and the development of severe respiratory failure or death in 8,000 patients hospitalized for SARS-CoV-2 infection in nine Spanish public hospitals.
  • To identify low-cost, non-invasive imaging markers (chest radiography and ultrasound), using radiology and artificial intelligence, to assess the risk of developing severe respiratory failure or dying in patients hospitalized for SARS-CoV-2 infection.

In the long term, the aim of CORSAIR is to evaluate the impact of SARS-CoV-2 infection on respiratory symptoms, lung function and structure, and biomarkers in a cohort of 500 survivors six months after discharge from hospitals.

Total funding

28,000 € in kind contrbution from ISGLobal and participating hospitals and data contribution from the Catalan Government.

Nuestro equipo


  • Judith Garcia
    Judith Garcia Jefa del programa de Enfermedades No Transmisibles y Medio Ambiente

ISGlobal team

Otros proyectos

Ver proyectos pasados


Estudio multi-caso control poblacional, incluyendo tumores de alta incidencia en España


Aging Lungs in European Cohorts


Physical Activity as a Crucial Patient Reported Outcome in COPD


Social and environmental determinants of physical activity in patients with chronic obstructive pulmonary disease (COPD): a qualitative and quantitative epidemiological study


Network on the Coordination and Harmonisation of European Occupational Cohorts


Impact Of Pollution on Asthma and Rhinitis


Valorización del Archivo Europeo del Genomas y Fenomas (EGA) para la Industria y la Sociedad


Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement


Cohorte Covid-19 en Cataluña


Signs of Early Adaptation to Climate Change


Exposure to emerging contaminants in drinking water in Barcelona potentially liked to chronic diseases and wellbeing


Las Voces de los Afectados por la Nefropatía Mesoamericana


Co-created educational programme for dyspnea-bearing patients and their caregivers


Risk of colorectal and breast cancer with widespread drinking water chemical contaminants


Cohorte de COVID-19 en España: dinámica social, salud mental y desigualdades


EXposome Powered tools for healthy living in urbAN SEttings


Air Pollution in Relation to COVID-19 Morbidity and Mortality: A Large Population-Based Cohort Study in Catalonia